A Randomized Trial of Ultrasound-Guided Acupotomy for Ankylosing Spondylitis
- Sponsor
- China-Japan Friendship Hospital
- Study ID
- NCT07578220
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ultrasound-guided acupotomy — PROCEDUREUltrasound-guided acupotomy will be performed once weekly for four consecutive weeks (W0-W3), for a total of four sessions. The target vertebral level and treatment sites will be identified by physical examination and ultrasound imaging. Following routine skin preparation and local anesthesia, the acupotomy needle will be advanced under real-time ultrasound guidance to the predefined interspinous and paraspinal treatment sites, where tissue release will be performed according to the standardized treatment protocol.
- Sham Acupotomy — PROCEDURESham acupotomy will be performed once weekly for four consecutive weeks (W0-W3), for a total of four sessions. The same preliminary procedures as those used in the experimental group will be followed, including physical examination, ultrasound localization, skin preparation, and local anesthesia. The acupotomy needle will only penetrate superficially, without advancement to the target deep tissues or performance of tissue release.
Study Details
This study employs a randomized controlled trial methodology to systematically evaluate the efficacy and safety of a modified acupotomy technique in the treatment of ankylosing spondylitis. Through ultrasound-guided localization, the operative sites are assessed to clarify the improvement effect of the modified acupotomy on disease activity in AS patients. The aim is to enhance the clinical outcomes of AS, provide evidence-based medical support for acupotomy treatment of AS, and improve the diagnosis and treatment standards for the condition.
Key Dates
- First listed
- May 11, 2026
- Start date
- Dec 2, 2025
- Status verified
- Sep 2026
- Primary completion
- Apr 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Ultrasound-guided acupotomy groupParticipants assigned to the experimental group will receive ultrasound-guided acupotomy once weekly for four consecutive weeks (W0-W3), for a total of four treatment sessions. Before each treatment, the target vertebral level and treatment sites will be identified by physical examination and ultrasound imaging. Following routine skin preparation and local anesthesia, the acupotomy needle will be advanced under real-time ultrasound guidance to the predefined interspinous and paraspinal treatment sites, where tissue release will be performed according to the standardized treatment protocol.
- Sham Comparator: Sham acupotomy groupParticipants assigned to the sham comparator group will receive a sham acupotomy procedure once weekly for four consecutive weeks (W0-W3), for a total of four sessions. The sham procedure will replicate the preliminary procedures used in the experimental group, including physical examination, ultrasound localization, skin preparation, and local anesthesia. However, the acupotomy needle will only penetrate superficially and no deep tissue release will be performed.
Primary Outcome Measure
Change from baseline in Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score [ Time Frame: Week 4,one week after the final treatment session ]
Central Contacts
- Yuqiao Zhang+86 13661102043
Related Studies
- Rheumatology Patient Registry and BiorepositoryRecruiting · Yale University · New Haven, Connecticut
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Exactech Shoulder Post Market Clinical Follow-up StudyRecruiting · Exactech · Laguna Woods, California
- IMPACT - AndHealth Autoimmune Research RegistryRecruiting · AndHealth · Columbus, Ohio